Ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopina
Name | Ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopina |
---|---|
Marketing Authorisation Number | HR-H-946413615 |
Active Substance | natrijev deksametazonfosfat levofloksacin hemihidrat |
Composition | jedan ml otopine sadrži 1 mg deksametazona (u obliku natrijevog deksametazonfosfata) i 5 mg levofloksacina (u obliku levofloksacin hemihidrata) |
Pharmaceutical Form | kapi za oko, otopina |
Manufacturer | Santen Oy, Tampere, Finska |
Marketing Authorisation Holder | Santen Oy, Niittyhaankatu 20, Tampere, Finska |
Marketing Authorisation Date | 20.07.2020 |
MA Period of Validity | 20.07.2025 |
Classification Number | UP/I-530-09/19-01/98 |
Registration Number | 381-12-01/38-20-04 |
Prescription | na recept |
Type of prescription | neponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | S01CA01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |